Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration

Reza Karkhaneh(Farabi Hospital), Khalil Ghasemi Falavarjani(Iran University of Medical Sciences), Mohammadreza Akhlaghi(Isfahan University of Medical Sciences), Hamid Riazi‐Esfahani(Farabi Hospital), Hooshang Faghihi(Farabi Hospital), Fatemeh Bazvand(Farabi Hospital), Hossein Ashraf(Shiraz University of Medical Sciences), Nazanin Ebrahimiadib(University of Florida), Hassan Khojasteh(University of Miami), Alireza Khodabande(Farabi Hospital), Hassan Behboudi(Guilan University of Medical Sciences), Maryam Dourandeesh(Twitter (United States)), Hamidreza Kafi, Fariba Ghassemi(Farabi Hospital), Araz Sabzvari(Biotechnology Research Center), Pejvak Azadi(Kermanshah University of Medical Sciences), Mohammad‐Reza Ansari‐Astaneh(Mashhad University of Medical Sciences), Elias Khalili Pour(Farabi Hospital), Mohammadkarim Johari(Shiraz University of Medical Sciences), Mojtaba Abrishami(Farabi Hospital), Nasser Shoeibi(Mashhad University of Medical Sciences), Marjan Imani Fooladi(Farabi Hospital), Mohammad Zarei(Farabi Hospital), Seyedeh Maryam Hosseini(Mashhad University of Medical Sciences), Yousef Alizadeh(Guilan University of Medical Sciences), Farhad Fazel(Isfahan University of Medical Sciences), Mostafa Feghhi(Ahvaz Jundishapur University of Medical Sciences), Ahmad Mirshahi(Farabi Hospital)
Ophthalmology Retina
February 28, 2024
Cited by 19


Related Papers